Braveheart Bio, Inc. (BRVE)

NASDAQ: BRVE · Real-Time Price · USD

25.97

-0.18 (-0.69%)

At close: Aug 13, 2026, 4:00 PM EDT

26.48

+0.51 (1.96%)

After-hours: Aug 13, 2026, 7:58 PM EDT

Braveheart Bio Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025
Operating Income	-19.46	-4.51
Net Income	-80.23	-66.05
Earnings Per Share	-2.63	-3.93
EPS Growth	-	-

Cash & Debt

Fiscal Year	Current	FY 2025
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025
Net Cash (Debt)	79.91	89.16
Net Cash Growth	-	-
Net Cash Per Share	2.62	5.30
Cash & Investments	79.91	89.16

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025
Operating Cash Flow	-7.2	-2.01
Free Cash Flow	-7.2	-2.01
Free Cash Flow Growth	-	-